home / stock / ghdx / ghdx news


GHDX News and Press, Genomic Health Inc. From 01/07/19

Stock Information

Company Name: Genomic Health Inc.
Stock Symbol: GHDX
Market: NASDAQ

Menu

GHDX GHDX Quote GHDX Short GHDX News GHDX Articles GHDX Message Board
Get GHDX Alerts

News, Short Squeeze, Breakout and More Instantly...

GHDX - Genomic Health Marks More than 1 Million Patients Worldwide Who Have Benefited from Oncotype DX Testing in Personalizing Cancer Treatment Decisions to Improve Outcomes

REDWOOD CITY, Calif. , Jan. 7, 2019 /PRNewswire/ --  Genomic Health, Inc.  (NASDAQ: GHDX) today announced that, in collaboration with physicians around the world, it has delivered more than 1 million Oncotype DX ® tests to cancer patients worldwide since it made its f...

GHDX - Genomic Health Is Positioned For Strong Returns

Genomic Health ( GHDX ) is a top provider of genomic-based diagnostic tests that help optimize cancer care, including addressing the overtreatment of the disease, one of the greatest issues in healthcare today. Genomic Health offers its tissue-based invasive breast, prostate, colon, and DCIS O...

GHDX - Multiple Oncotype DX Study Presentations at the 2018 San Antonio Breast Cancer Symposium Reinforce Real-world Value of the Oncotype DX Breast Recurrence Score® Test in Patients Regardless of Age or Race

REDWOOD CITY, Calif. , Dec. 10, 2018 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced results from multiple Oncotype DX Breast Recurrence Score ® (RS) presentations at the 2018 San Antonio Breast Cancer Symposium ® (SABCS), reinforcing the value of the Oncot...

GHDX - Genomic Health and Biocartis Expand Collaboration to Urology with the Development of an Idylla(TM) Oncotype DX® Genomic Prostate Score® Test

REDWOOD CITY, Calif. and MECHELEN, Belgium , Dec. 3, 2018 /PRNewswire/ --  Genomic Health , Inc. (NASDAQ: GHDX), the world's leading provider of genomic-based diagnostic tests and Biocartis Group NV, an innovative molecular diagnostics company (Euronext Brussels: BCART), today ...

GHDX - Undervalued Stocks With Rising Earnings Expectations

Simplicity is the ultimate sophistication. The more simple and straightforward the rationale for buying a stock, the better the chances of success. At the end of the day, investing is all about answering two main questions: what to buy and when to buy it. This article is introducing a quanti...

GHDX - Genomic Health Q3 beat and guidance raise propel shares, up 24%

Genomic Health ( GHDX +23.5% ) is up on modestly higher volume after releasing better-than-expected results after the close yesterday. Highlights: More news on: Genomic Health, Inc., Read more ...

GHDX - Genomic Health, Inc. (GHDX) CEO Kim Popovits on Q3 2018 Results - Earnings Call Transcript

Genomic Health, Inc. (GHDX) Q3 2018 Results Conference Call November 06, 2018 04:30 PM ET Executives Emily Faucette - Vice President of Corporate Communications and Investor Relations Kim Popovits - Chairman of the Board, Chief Executive Officer and President Brad Cole - Chief Fi...

GHDX - Genomic Health beats by $0.27, beats on revenue

Genomic Health (NASDAQ: GHDX ): Q3 GAAP EPS of $0.32 beats by $0.27 . More news on: Genomic Health, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, Read more ...

GHDX - Genomic Health Announces Record Revenue and Profit in Third Quarter 2018 Financial Results; Raises Full Year Guidance

REDWOOD CITY, Calif. , Nov. 6, 2018 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today reported financial results and business progress for the quarter ended September 30, 2018 . "We continue to deliver record results in 2018, including 23 percent revenue growth and $...

GHDX - Notable earnings after Tuesday's close

ACAD , AAXN , AIZ , APEI , ASH , BEL , BOLD , BWXT , CHUY , COHR , CPE , CSLT , CUTR , CWH , DAR , DATA , DIOD , DK , DOOR , DPLO , DVN , DXC , DXCM , EGN , ENLC , ENLK , ENPH , ETSY , EVH , EVRI , FANG , FIVN , FTK , FTR , G , GDDY , GHDX , GLUU , HAL...

Previous 10 Next 10